Comparison of the effects of hypolipidaemic treatment on monocyte proinflammatory cytokine release in men and women with type 2 diabetes and atherogenic dyslipidaemia

被引:9
|
作者
Krysiak, Robert [1 ]
Gdula-Dymek, Anna [1 ]
Marek, Bogdan [2 ,3 ]
Okopien, Boguslaw [1 ]
机构
[1] Med Univ Silesia, Dept Internal Med & Clin Pharmacol, PL-40752 Katowice, Poland
[2] Med Univ Silesia, Div Pathophysiol, Dept Pathophysiol & Endocrinol, Zabrze, Poland
[3] Third Prov Hosp, Endocrinol Ward, Rybnik, Poland
关键词
sex; simvastatin; fenofibrate; atherogenic dyslipidaemia; monocytes; cytokines; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; PPAR-ALPHA; ATHEROSCLEROSIS; RISK; FENOFIBRATE; INHIBITION; MECHANISMS; PREVENTION;
D O I
10.5603/EP.2015.0029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Statins and fibrates reduce monocyte release of proinflammatory cytokines, but it remains unknown whether this effect is sex dependent. Material and methods: We retrospectively analysed age-, weight-, and lipid-matched populations of type 2 diabetic patients of both sexes, who, because of atherogenic dyslipidaemia, were treated with simvastatin (40 mg daily), fenofibrate (200 mg daily), or simvastatin plus fenofibrate. Monocyte release of tumour necrosis factor alpha (TNF-alpha), inteleukin-1 beta, interleukin-6, and monocyte chemoattractant protein-1 (MCP-1), as well as circulating levels of high-sensitivity C-reactive protein (hsCRP) and free fatty acids (FFA) were assessed separately for men and women before and after 12 weeks of treatment. Results: Baseline monocyte release of TNF-alpha, interleukin-1 beta, interleukin-6, and MCP-1, as well as plasma hsCRP and FFA levels were comparable in both sexes. Simvastatin, fenofibrate, and simvastatin/fenofibrate combination therapy reduced monocyte release of TNF-alpha, inteleukin-1 beta, interleukin-6, and MCP-1, with no difference between the treatment groups. The impact of simvastatin and fenofibrate administered alone on monocyte cytokine release and systemic inflammation did not differ between the men and women. The effect of simvastatin/fenofibrate combination therapy on monocyte release of interleukin-6 and MCP-1 was more pronounced in the male population. The impact of simvastatin administered together with fenofibrate on TNF-alpha, interleukin-1 beta, and hsCRP was also stronger in the men than in the women, but the difference did not reach the level of significance. Conclusions: The obtained results suggest that sex differences determine the strength of the monocyte-suppressing effect of simvastatin//fenofibrate combination therapy in type 2 diabetic patients with atherogenic dyslipidaemia.
引用
收藏
页码:224 / 230
页数:7
相关论文
共 50 条
  • [21] The effects of early life stress and gender upon depression in African-American men and women with type 2 diabetes
    Smith, Shoi D.
    Binongo, Jose
    Ziemer, David C.
    Barham, Terrika
    Brown, Angelo R.
    Phillips, Lawrence
    Bruce, Erica
    Musselman, Dominique L.
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 234S - 234S
  • [22] Men and women with chronic systolic heart failure and with/without concomitant 2 type diabetes: comparison of survival and clinical data.
    Tkach, N. Nataliya
    Voronkov, L.
    Filatova, H.
    Dudnik, H.
    Gavrilenko, T.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 147 - 147
  • [23] Comparison of Various Lipid Variables as Predictors of Coronary Heart Disease in Japanese Men and Women With Type 2 Diabetes Subanalysis of the Japan Diabetes Complications Study
    Sone, Hirohito
    Tanaka, Sachiko
    Tanaka, Shiro
    Iimuro, Satoshi
    Ishibashi, Shun
    Oikawa, Shinichi
    Shimano, Hitoshi
    Katayama, Shigehiro
    Ohashi, Yasuo
    Akanuma, Yasuo
    Yamada, Nobuhiro
    DIABETES CARE, 2012, 35 (05) : 1150 - 1157
  • [24] Monocyte-derived macrophages from men and women with Type 2 diabetes mellitus differ in fatty acid composition compared with non-diabetic controls
    Senanayake, Saranga
    Brownrigg, Leon M.
    Panicker, Vijay
    Croft, Kevin D.
    Joyce, David A.
    Steer, James H.
    Puddey, Ian B.
    Yeap, Bu B.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 75 (03) : 292 - 300
  • [25] Conjugated linoleic acid reduces glycated protein COX-2 expression and inflammatory cytokine release in human moneytes: A potential anti-atherogenic role for polyunsaturated fatty acids in type 2 diabetes
    Lin, TT
    Evans, M
    Rees, A
    Tonks, A
    Roberts, A
    Thomas, A
    Morris, K
    DIABETES, 2003, 52 : A177 - A177
  • [26] Effects of the new adiponectin paralogous protein CTRP-3 and of LPS on cytokine release from monocytes of patients with type 2 diabetes mellitus
    Kopp, Andrea
    Bala, Margarita
    Weigert, Johanna
    Buechler, Christa
    Neumeier, Markus
    Aslanidis, Charalampos
    Schoelmerich, Juergen
    Schaeffler, Andreas
    CYTOKINE, 2010, 49 (01) : 51 - 57
  • [27] Effects of Treatment With Risedronate and Alfacalcidol on Progression of Atherosclerosis in Postmenopausal Women With Type 2 Diabetes Mellitus Accompanied With Osteoporosis
    Kanazawa, Ippei
    Yamaguchi, Toru
    Hayashi, Kumi
    Takase, Hirofumi
    Shimizu, Tadashi
    Sugimoto, Toshitsugu
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2010, 339 (06): : 519 - 524
  • [28] Women with type 2 diabetes have LDL cholesterol levels higher than those of men, regardless of their treatment and their cardiovascular risk level
    Paquet, Sylvain
    Sassenou, Jeanne
    Ringa, Virginie
    Czernichow, Sebastien
    Zins, Marie
    Ozguler, Anna
    Rigal, Laurent
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2023, 33 (06) : 1254 - 1262
  • [29] Lifetime risk to progress from pre-diabetes to type 2 diabetes among women and men: comparison between American Diabetes Association and World Health Organization diagnostic criteria
    van Herpt, Thijs T. W.
    Ligthart, Symen
    Leening, Maarten J. G.
    van Hoek, Mandy
    Lieverse, Aloysius G.
    Ikram, M. Arfan
    Sijbrands, Eric J. G.
    Dehghan, Abbas
    Kavousi, Maryam
    BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (02)
  • [30] Effects of a Combined Endurance/Strength Training Program on Circulating Irisin Levels in Overweight/Obese Men and Women with Type 2 Diabetes Mellitus
    Brinkmann, Christian
    Weh-Gray, Olivier
    Bloch, Wilhelm
    Brixius, Klara
    Predel, Hans-Georg
    Kreutz, Thorsten
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2022, 130 (01) : 37 - 42